Chunfeng Qian
Overview
Explore the profile of Chunfeng Qian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Comparative analysis of improved m6A sequencing based on antibody optimization for low-input samples
Lu J, Xia W, Li J, Zhang L, Qian C, Li H, et al.
Sci Rep
. 2025 Jan;
15(1):1058.
PMID: 39774984
The most effective method for mapping N6-methyladenosine (mA) is mA RNA immunoprecipitation sequencing (MeRIP-seq). The quality of MeRIP-seq relies on various factors, with the anti-mA antibody being a crucial determinant....
2.
Hu X, Lu J, Ding C, Li J, Zou Q, Xia W, et al.
Aging Cell
. 2024 Oct;
24(2):e14376.
PMID: 39410722
The versatile epigenetic modification known as N6-methyladenosine (mA) has been demonstrated to be pivotal in numerous physiological and pathological contexts. Nonetheless, the precise regulatory mechanisms linking mA to histone modifications...
3.
Qian C, Liu Z, Qian Y, Ding J, Chen R, Su H, et al.
Genes Dis
. 2024 Jan;
11(3):101050.
PMID: 38292188
No abstract available.
4.
Wu Y, Li J, Li C, Lu S, Wei X, Li Y, et al.
J Biol Chem
. 2023 May;
299(6):104783.
PMID: 37146971
N6-methyladenosine (m6A) is the most prevalent reversible RNA modification in the mammalian transcriptome. It has recently been demonstrated that m6A is crucial for male germline development. Fat mass and obesity-associated...
5.
Qian C, Meng Q, Lu J, Zhang L, Li H, Huang B
Stem Cell Res Ther
. 2020 Jul;
11(1):290.
PMID: 32678012
Background: Before starting gonadotoxic therapies, cryopreservation of mature sperm has been proposed worldwide as a method for male fertility preservation and for enabling the conception of a healthy baby with...
6.
Ding C, Qian C, Hou S, Lu J, Zou Q, Li H, et al.
Mol Ther Nucleic Acids
. 2020 Jun;
21:37-50.
PMID: 32506013
Human amniotic mesenchymal stem cells (hAMSCs) were previously shown to effectively rescue ovarian function in a premature ovarian insufficiency (POI) mouse model. The therapeutic mechanism of hAMSC-derived exosomes (hAMSC-Exos) is...
7.
Hou S, Ding C, Shen H, Qian C, Zou Q, Lu J, et al.
Stem Cell Res Ther
. 2020 Apr;
11(1):159.
PMID: 32321569
Background: Human amniotic epithelial cell (hAEC) transplantation holds great promise in treating premature ovarian insufficiency (POI). However, some deficient biological characteristics of hAECs restrict their application. Methods: Vitamin C (VC)...
8.
Ou J, Yang C, Cui X, Chen C, Ye S, Zhang C, et al.
Reprod Biol Endocrinol
. 2020 Mar;
18(1):15.
PMID: 32113484
Background: The study is aimed to provide prediction for fertility risk in the setting of assisted reproduction for a woman with complex chromosomal rearrangements (CCRs). Methods: We implemented a robust...
9.
Ding C, Zou Q, Wu Y, Lu J, Qian C, Li H, et al.
Aging (Albany NY)
. 2020 Feb;
12(3):2992-3009.
PMID: 32040445
Human placental mesenchymal stem cells (hPMSCs) have the ability to release cytokines and to differentiate into the three germ layers. To date, the relevance of hPMSCs for the treatment of...
10.
Huang B, Qian C, Ding C, Meng Q, Zou Q, Li H
Stem Cell Res Ther
. 2019 Dec;
10(1):362.
PMID: 31783916
Background: With the development of regenerative medicine and tissue engineering technology, almost all stem cell therapy is efficacious for the treatment of premature ovarian failure (POF) or premature ovarian insufficiency...